Press Enter to search · ESC to close

US Stocks

Sellas Life Sciences Shares Jump 220% on Positive Late-Stage Vaccine Data

Sellas Life Sciences shares opened up 220% after the drug developer said Tuesday its experimental vaccine for a blood cancer produced positive late-stage clinical trial results, significantly extending patients’ survival time. The opening surge was reported by market data platform MSX.COM.

Share

Related News

新云社 share card
Long-press image above → Save to Photos / Share
Pitch us Feedback